Metraipolis › archive › dc_e9820168d990
P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders — Europe PMC PMID:42698301
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42698301
- DOI
- 10.1002/cns.71139
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T12:30:08.062Z
- SHA-256 of the archived text
5e05a3241b29e5f5e15b72d2387092083643a4ee442bc6c3f32defbb0f905283- Stable URL of this page
https://metraipolis.com/documento/dc_e9820168d990
How to cite
P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders — Europe PMC PMID:42698301 — Europe PMC (en), https://europepmc.org/article/MED/42698301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9820168d990 (Metraipolis archive dc_e9820168d990, sha256 5e05a3241b29e5f5e15b72d2387092083643a4ee442bc6c3f32defbb0f905283)
BibTeX
@misc{dce9820168d990,
title = {P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders — Europe PMC PMID:42698301},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42698301},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9820168d990; sha256 5e05a3241b29e5f5e15b72d2387092083643a4ee442bc6c3f32defbb0f905283},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42698301. Agents can read the archived copy with the MCP tool read_document.